WEE1 and neoplasm: Applying WEE1 inhibitors to tumor cells revealed a significant reduction in the expression of M2 macrophages and Treg immunosuppressive cells in TME, reversing the suppressive TME and increasing the sensitivity of tumor cells to immunotherapy (Jin et al., 2021).